RxDoctor Payments Data

Katherine McCrady, PA

Medical · Little Rock, ARNPI 1023452174

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.0% of the total across 479 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,037in general payments, 2019–2025

Across 479 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$2K
  • Sun Pharmaceutical Industries Inc.$1K
  • Novartis$1K
  • AbbVie$1K
  • UCB, Inc.$720
  • LEO Pharma Inc.$635
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$8,49494%
  • Education$5436%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,037 in reported general payments places this provider in the 95th percentile of 133 medical providers in Arkansas.

See all medical providers in Arkansas

Medicare billing

Part B allowed, 2024
$265,596
Medicare patients
864
Services billed
7,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bimzelx AutoinjectorBimekizumab-Bkzx30$420,725
Taltz AutoinjectorIxekizumab21$146,239
Dupixent PenDupilumab22$81,694
Dupixent SyringeDupilumab16$61,719
Clobetasol Propionate69$3,400
Ketoconazole183$3,382
Metronidazole29$1,287
Imiquimod50$861
Clindamycin Phosphate36$782
Fluocinonide15$741
Betamethasone Dipropionate15$657
Cephalexin12$631
Triamcinolone Acetonide73$570
Terbinafine Hcl20$225
Mupirocin27$214

Paid to pharmacies, not to this prescriber.

Other medical in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →